Best Masld Podcasts (2024)

1
S5 - E24 - A view of MASLD: Looking back at EASL Congress from six weeks later 1:16:26

10d ago1:16:26

1:16:26

00:00:00 - Surf's Up: Season 5 Episode 24 This week's episode on MASLD lessons from the EASL Congress 2024 includes three separate elements: individual interviews with PharmaNext Founder and CEO Mathieu Petitjean and Global Liver Institute Vice President of Liver Programs Jeff McIntyre, followed by a discussion with patient advocates Mike Betel of …

1
Angela Lamarca, MD, PhD, MSc - Prioritising Patient-Centric Care in Biliary Tract Cancer: Leveraging Immunotherapy Platforms to Overcome Challenges in the Advanced Setting 22:50

5d ago22:50

22:50

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/EUX865. CME credit will…

1
Angela Lamarca, MD, PhD, MSc - Prioritising Patient-Centric Care in Biliary Tract Cancer: Leveraging Immunotherapy Platforms to Overcome Challenges in the Advanced Setting 22:50

3h ago22:50

22:50

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/EUX865. CME credit will…

1
S5 - E25 - Reviewing Expert Recommendations on the Use of Resmetirom 42:02

4d ago42:02

42:02

By HEP Dynamics LLC

1
S4 - E24.5 - SurfingMASH Question of The Week: Keys to Improving Provider-Patient Communication 20:14

5d ago20:14

20:14

Two weeks ago, the SurfingMASH Question of the Week asked, "What structural or educational changes do you anticipate will significantly improve Provider-Patient communication? Will these changes require more from the provider and more from the patient?" Today, S5 E23 panelists Mike Betel and José Willemse join Roger Green to review the three answer…

1
S5 - E24.4 - EASL Congress Six Weeks Later: Jeff McIntyre's Key Implications for GLI 18:28

6d ago18:28

18:28

In the second half of Roger Green's interview with Global Liver Institute Vice President, Liver Programs Jeff McIntyre, Jeff discusses the implications of his key EASL Congress takeaways for GLI and other patient advocacy groups. To Jeff, this trend makes patient advocates a more valuable player in the clinical trial design process, particularly wh…

1
S5 - E24.3 - EASL Congress Six Weeks Later: Jeff McIntyre's Key Takeaways 12:46

6d ago12:46

12:46

This conversation contains the first half of Roger Green's interview with Global Liver Institute Vice President, Liver Programs Jeff McIntyre, during which the two discuss what Jeff considered the key strategic takeaways for GLI from the various EASL Congress presentations, abstracts and discussions. Jeff focuses on the "overriding sense of optimis…

1
S5 - E24.2 - EASL Congress Six Weeks Later: Mathieu Petitjean's Key Implications 10:58

6d ago10:58

10:58

In the second half of Roger Green's interview with PharmaNest Founder and CEO Mathieu Petitjean, Matt discusses the implications of his key EASL Congress takeaways for PharmaNest. Matt starts this discussion with a simple question: Will biopsy-based analyses become part of a surrogate endpoint? As he points out, they are not today, and creating the…

1
S5 - E24.1 - EASL Congress Six Weeks Later: Mathieu Petitjean's Key Takeaways 17:10

6d ago17:10

17:10

This conversation contains the first half of Roger Green's interview with PharmaNest Founder and CEO Mathieu Petitjean. After Matt tells the audience a little about his background and PhramaNest, the two discuss what Matt considered the key strategic takeaways for PharmaNest from the various EASL Congress presentations, abstracts and discussions. B…

1
Protective function of sclerosing cholangitis on IBD 8:20

12d ago8:20

8:20

Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Samuel Huber, from the Department of Medicine, University Medical Center, Hamburg-Eppendorf, Hamburg, Germany, on the paper "Protective function of sclerosing cholangitis on IBD" publish…

1
S5 SPECIAL 5 - Reviewing EASL Congress: Louise Campbell 3 (first-time material) 9:48

1M ago9:48

9:48

This week, Surfing the MASH Tsunami looks back on interviews Roger Green conducted during the EASL Congress itself. This conversation with SurfingMASH co-host and Tawazun Health Founder and Clinical Director Louise Campbell took place on the last day of the Congress This portion of the conversation was not included in the original S5 E19 but instea…

1
S5 SPECIAL 4 - Reviewing EASL Congress: Sven Francque 17:12

1M ago17:12

17:12

This week, Surfing the MASH Tsunami looks back on interviews Roger Green conducted during the EASL Congress itself. This conversation with Hepatology Key Opinion Leader and EASL Educational Councillor Sven Francque took place 90 minutes after the EASL Congress closed. The discussion focuses on plans and hopes for the future, both the future of MASL…

1
S5 SPECIAL 3 - Reviewing EASL Congress: Louise Campbell 2 20:47

1M ago20:47

20:47

This week, Surfing the MASH Tsunami looks back on interviews Roger Green conducted during the EASL Congress itself. This conversation with SurfingMASH co-host and Tawazun Health Founder and Clinical Director Louise Campbell took place on the last day of the Congress. This conversation centered on three major topics addressed at the EASL Congress, e…

1
S5 SPECIAL 2 - Reviewing EASL Congress: Louise Campbell I 20:13

1M ago20:13

20:13

This week, Surfing the MASH Tsunami looks back on interviews Roger Green conducted during the EASL Congress itself. This conversation with SurfingMASH co-host and Tawazun Health Founder and Clinical Director Louise Campbell took place on the first day of the Congress. Roger's first interview with Louise took place at the end of Thursday, the openin…

1
S5 SPECIAL 1 - Reviewing EASL Congress: Mike Betel 13:04

1M ago13:04

13:04

This week, Surfing the MASH Tsunami looks back on interviews Roger Green conducted during the EASL Congress itself. This conversation with Fatty Liver Alliance Founder and CEO Mike Betel took place Wednesday of Congress week, a day for special sections and industry presentations, but one day before the General Session opened. The first part of the …

1
S5 - E23.6 - From The Vault: Improving Patient Self-Management And Key Takeaways On Nutrition For MASH Resolution 29:50

1M ago29:50

29:50

This week’s vault comes from our first episode with Shira Zelber-Sagi. She and Ken Cusi joined us during US Thanksgiving Week 2022 to discuss nutrition and behavioral issues related to MASLD. The episode’s original writeup explains: Surfing the MASH Tsunami hosts its first episode dedicated to nutrition and NASH with distinguished guest, Prof. Shir…

1
S5 - E23.5 - From the EASL Congress: The Need for Shared Experience MASLD Support Groups and Programs 11:45

1M ago11:45

11:45

Co-chairs Shira Zelber-Sagi and Mike Betel and panelists Tom Marjot and José Willemse, all from the EASL Congress session "Patient Experiences in Clinical Settings," join Louise Campbell to the need for resources that allow MASLD patients to access shared experience programs and holistic MASLD support programs. This final conversation focuses on sh…

1
S5 - E23.4 - From the EASL Congress: Socioeconomic And Psychological Issues In The Physician-Patient Dialogue 12:20

1M ago12:20

12:20

Co-chairs Shira Zelber-Sagi and Mike Betel and panelists Tom Marjot and José Willemse, all from the EASL Congress session "Patient Experiences in Clinical Settings," join Louise Campbell to discuss ways that socioeconomic and psychological issues impact the dynamic of the physician-patient consult, and, as a result, often patient adherence to thera…

1
S5 - E23.3 - From The EASL Congress: Improving The Physician-Patient Dialogue 12:25

1M ago12:25

12:25

Co-chairs Shira Zelber-Sagi and Mike Betel and panelists Tom Marjot and José Willemse, all from the EASL Congress session "Patient Experiences in Clinical Settings," join Louise Campbell to discuss strategies and questioning styles that can improve the dynamic of the physician-patient consult. This conversation starts with Tom stating that having m…

1
S5 - E23.2 - From The EASL Congress: Dynamics Of The Physician-Patient Dialogue 11:29

1M ago11:29

11:29

Co-chairs Shira Zelber-Sagi and Mike Betel and panelists Tom Marjot and José Willemse, all from the EASL Congress session "Patient Experiences in Clinical Settings," join Louise Campbell to discuss some of the key dynamics shaping the physician-patient consult. This conversation starts with Mike asking Tom whether he reviews the patient's history b…

1
S5 - E23.1 - From The EASL Congress: Overview Of Challenges In Physician-Patient Communication 14:38

1M ago14:38

14:38

Co-chairs Shira Zelber-Sagi and Mike Betel and panelists Tom Marjot and José Willemse, all from the EASL Congress session "Patient Experiences in Clinical Settings," join Louise Campbell to provide an overview of issues in physician-patient communication. The conversation itself has two elements. It starts with first-time surfers Tom Marjot and Jos…

1
S5 - E23 - Lessons from EASL Congress: Challenges in Provider-Patient Communication 58:52

1M ago58:52

58:52

00:00:00 - Surf's Up: Season 5 Episode 23 During SurfingMASH's wrap-up interviews from the EASL Congress (S5 E19), Louise Campbell and Mike Betel mentioned a session Mike co-chaired on challenges in provider-patient communications. Today, the other co-chair, Shira Zelber-Sagi and panelists Tom Marjot and Jose Willemse join Louise and Mike to return…

1
S5 - E22.6 - FROM THE VAULT: Patient Advocates Reflect On How The "System" Views MASH 12:29

2M ago12:29

12:29

In this week's episode, Jeff Lazarus discusses the idea that the MASH community, including patient advocates, live in a "bit of a bubble," where the clinicians with whom they interact are part of the MASH community. Last year's ICER Public Comments session exposed them to an FDA Advisory Board of hepatologists...and it was a very different experien…

1
S5 - E22.5 - Healthy Livers, Healthy Lives: Watershed Moments To Come In MASLD Publlc Policy 10:49

2M ago10:49

10:49

In this closing conversation, Healthy Livers, Healthy Lives Chair Jeff Lazarus and Surfers Jörn Schattenberg, Louise Campbell and Roger Green discuss the upcoming United Nations General Assembly side event and consider ways listeners can support the "Healthy LIvers, Healthy Lives" coalition. Jeff discussed this impact on global care when the World …

1
S5 - E22.4 - Healthy Livers, Healthy Lives: The Role Of The Updated EASL MASLD Guidelines And Big Data 10:44

2M ago10:44

10:44

Healthy Livers, Healthy Lives Chair Jeff Lazarus joins Jörn Schattenberg, Louise Campbell and Roger Green to discuss the value of the updated EASL/EASD/EASO MASLD clinical practice guidelines and consider the role of Big Data in early MASLD screening. Roger asks Jeff whether he considers the updated MASLD CPG a step forward. Jeff praises the guidel…

1
S5 - E22.3 - Healthy Livers, Healthy Lives: Challenges and Promise in Building a Global MASLD Health Policy 10:54

2M ago10:54

10:54

Healthy Livers, Healthy Lives Chair Jeff Lazarus joins Jörn Schattenberg, Louise Campbell and Roger Green to discuss some of the specific structural challenges that confront global MASLD public policy, along with some promising local activities. Louise observes that, in her experience, primary care practitioners appreciate the support that speciali…

1
S5 - E22.2 - Healthy Livers, Healthy Lives: "Political Will" In MASLD Public Policy 12:14

2M ago12:14

12:14

Healthy Livers, Healthy Lives Chair Jeff Lazarus joins Jörn Schattenberg, Louise Campbell and Roger Green to discuss why political will is so important in overcoming inertia and obstruction in global MASLD public health policy. Louise notes that she left NHS because of obstruction against earlier stage efforts to promote liver health and asks how t…

1
S5 - E22.1 - Healthy Livers, Healthy Lives: Why MASHville Needs This Coalition 13:29

2M ago13:29

13:29

Healthy Livers, Healthy Lives Chair Jeff Lazarus joins Jörn Schattenberg, Louise Campbell and Roger Green to discuss how the coalition came into existence and to describe two initiatves aimed at increasing early screening. Jeff starts the conversation by describing the "bit of a bubble" in which the MASLD community lives: great news and lots of exc…

1
S5 - E22 - Healthy Livers, Healthy Lives: A Global SLD Public Health Coalition 45:08

2M ago45:08

45:08

00:00:00 - Surf's Up: Season 5 Episode 22 Jeff Lazarus joins Jörn Schattenberg, Louise Campbell and Roger Green to discuss Healthy Livers, Healthy Lives, a coalition of four major professional organizations (AASLD, ALEH, APASL and EASL) and other partners. This coalition works with other specialties to create global public health awareness and driv…

1
Linking high-fat diet and liver tumorigenesis 13:46

2M ago13:46

13:46

Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Jianping Guo from Institute of Precision Medicine, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China, on the paper "High-fat diet promotes liver tumorige…

1
S5 - E21.6 - From The Vault: Comments On The 2023 AASLD Revised Practice Guidance 11:05

2M ago11:05

11:05

This week's vault conversation looks back 17 months when Ken Cusi joined co-hosts Louise Campbell, Jörn Schatenberg and Roger Green to discuss the revised AASLD Practice Guidance that had been issued the previous week. At the time, here was SurfingMASH's summary of the conversation: Late last week, AASLD published new practice guidance on the clini…

1
S5 - E21.5 - The Updated MASLD CPG: Implications For Healthcare Systems 12:08

2M ago12:08

12:08

In this closing conversation, updated MASLD CPG co-authors Frank Tacke and Elisabetta Bugianesi and podcast co-hosts Louise Campbell and Roger Green consider what the guidelines might foretell in changes in provider education, structure of patient visits and treatment in less affluent or medically advanced countries. The last set of questions begin…

1
S5 - E21.4 - The Updated MASLD CPG: Pharmacology And New Educational Needs 11:04

2M ago11:04

11:04

For most of this conversation, updated MASLD CPG co-authors Frank Tacke and Elisabetta Bugianesi discuss key issues related to pharmacology and prescribing choices. At the end, the focus shifts to the guidelines' overall benefits and some new kinds of education they call for. The conversation starts with co-host Roger Green asking about key issues …

1
S5 - E21.3 - The Updated MASLD CPG: Screening, Diagnosing And Managing Patients 13:20

2M ago13:20

13:20

In this conversation, updated MASLD CPG co-authors Frank Tacke and Elisabetta Bugianesi discuss some of the guidelines' key goals and issues surrounding the screening, diagnosis and management of MASLD patients. As the conversation starts, co-host Roger Green says that he, too, was impressed that all these adjustments were made within a month at th…

1
S5 - E21.2 - The Updated MASLD CPG: Benefits Of The Collaboration 11:00

2M ago11:00

11:00

In this conversation, updated MASLD CPG co-authors Frank Tacke and Elisabetta Bugianesi explain how the guidelines process benefitted from the close collaboration between EASL, EASD, and EASO. The conversation starts with Elisabetta conveying the "big advantage" that came from this collaboration. The presence of the three organizations conveyed the…

1
S5 - E21.1 - The Updated MASLD CPG: Introductions 9:21

2M ago9:21

9:21

Two of the co-authors of the upgraded MASLD Clinical Practice Guidelines, Elisabetta Bugianesi and Frank Tacke join Louise Campbell and Roger Green to discuss the guidelines. The theme for the conversation is "introductions". First, the audience is introduced to co-authors Elisabetta Bugianesi and Frank Tacke, neither of whom has Surfed the Tsunami…

1
S5 - E21 - Reviewing The Updated ESL-EASD-EASO MASLD Clinical Practice Guidelines 52:15

2M ago52:15

52:15

00:00:00 - Surf's Up: Season 5 Episode 21 One important session at the EASL Congress 2024 involved the presentation of the new MASLD Clinical Practice Guidelines. CPG co-authors Elisabetta Bugianesi and Frank Tacke join Louise Campbell and Roger Green to share their perspectives on the guidelines' development some key recommendations. 00:09:36 - Re…

1
Yelena Y. Janjigian, MD - Precision Tactics in HER2-Positive GI Malignancies: Capitalizing on HER2-Targeted Regimens to Improve Outcomes for Gastric/GEJ Cancers, CRC, and BTC 1:22:40

2M ago1:22:40

1:22:40

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/JPD8…

1
Manish A. Shah, MD, FASCO - Catalysts for Change in Gastric and GEJ Cancer: Digesting New Evidence and Future Directions of Care With Innovative Immunotherapy and Targeted Platforms 1:35:10

2M ago1:35:10

1:35:10

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/VTE865. C…

1
Manish A. Shah, MD, FASCO - Catalysts for Change in Gastric and GEJ Cancer: Digesting New Evidence and Future Directions of Care With Innovative Immunotherapy and Targeted Platforms 1:35:13

2M ago1:35:13

1:35:13

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/VTE865. C…

1
Yelena Y. Janjigian, MD - Precision Tactics in HER2-Positive GI Malignancies: Capitalizing on HER2-Targeted Regimens to Improve Outcomes for Gastric/GEJ Cancers, CRC, and BTC 1:22:29

2M ago1:22:29

1:22:29

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/JPD8…

1
S5 - E20.6 - From the Vault: FGF-21s and "Twin-cretins" At EASL Congress 2023 14:25

2M ago14:25

14:25

In this conversation from July 2023, Stephen Harrison, Jörn Schattenberg and Roger Green discuss the implications of presentations on the FGF-21 agent efruxifermin and the dual GLP/glucagon agonists pemvidutide and efinopegdutide. Here is the description Roger wrote for the original conversation: In this session, conversation shifts from resmetirom…

1
S5 - E20.5 - Drug Development Highlights From EASL Congress 2024: Denifenstat, SPECIAL and Other Stories 13:28

2M ago13:28

13:28

Mazen Noureddin and Naim Alkhouri join Jörn Schattenberg and Roger Green to discuss some of the other major drug development stories from the EASL Congress 2024, with special focus on denifenstat, ION-224 and TAK-227, and to review the SPECIAL study on bariatric surgery and cirrhosis. The panelists concur that all three of these agents have potenti…

1
S5 - E20.4 - Drug Development Highlights From EASL Congress 2024: Are FGF-21s Induction Therapy or a "MASH Cure"? 10:05

2M ago10:05

10:05

Mazen Noureddin and Naim Alkhouri join Jörn Schattenberg and Roger Green to focus on the role FGF-21s will play in long-term advanced fibrosis treatment: induction or long-term therapy...or might we even think of the class as being able to produce a "MASH cure?" Responding to Naim's comment closing the previous discussion, Mazen questions why we re…

1
S5 - E20.3 - Drug Development Highlights From EASL Congress 2024: "Twin-cretins" and efruxifermin 14:35

2M ago14:35

14:35

Naim Alkhouri and Mazen Noureddin join Jörn Schattenberg and Roger Green to discuss issues regarding incretin agonists and results from the efruxiermin late-breaker at the EASL Congress 2024. Naim shares his general excitement about glucagon agents in general. He mentions that the efinopegdutide study included a semaglutide cell, which showed furth…

1
S5 - E20.2 - Drug Development Highlights From EASL Congress 2024: Tirzepatidate and other "Twin-cretins" 11:46

2M ago11:46

11:46

Mazen Noureddin and Naim Alkhouri join Jörn Schattenberg and Roger Green to discuss the tirzepatide late-breaker at the EASL Congress 2024 and other "Twin-cretins," all of which are GLP-glucagon combinations. "Twin-cretins" is the name Jörn has coined for agents with a GLP-1 agonist plus another incretin effect. Tirzepatide is a GLP/GIP agent, whil…

Podcasts Worth a Listen

Masld Podcasts

Podcasts Worth a Listen

Quick Reference Guide